Dr. Mandanas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5911 W Memorial Rd
Oklahoma City, OK 73142Phone+1 405-773-6400Fax+1 405-621-5441
Summary
- Dr. Romeo Mandanas is an oncologist in Oklahoma City, OK and is affiliated with INTEGRIS Baptist Medical Center. He received his medical degree from Cebu Institute of Medicine and has been in practice 34 years. He also speaks multiple languages, including Tagalog and Filipino. He specializes in hematologic oncology and is experienced in colorectal cancer, amyloidosis, hematologic oncology, myelodysplasia, and myelofibrosis.
Education & Training
- Indiana University School of MedicineFellowship, Blood & Bone Marrow Transplant, 1992 - 1993
- Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1989 - 1992
- Wayne State University1986 - 1989
- Philippine General HospitalResident, 1985 - 1986
- Chinese General HospitalInternship, 1983 - 1984
- Cebu Institute of MedicineClass of 1983
- University of San CarlosB.S, Biology, Summa cum laude, 1975 - 1979
Certifications & Licensure
- IN State Medical License 1989 - 2025
- OK State Medical License 1993 - 2025
- NV State Medical License 2008 - 2023
- IL State Medical License 1988 - 1996
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected to Fellowship American College of Physicians, 1998
- Fellow (FACP) American College of Physicians, 1998
- Physician's Recognition Award for Most Outstanding Intern 1984
- Join now to see all
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsPegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Ho...Robert M. Rifkin, Gary Spitzer, Gregory Orloff, Romeo A. Mandanas, Dean S. McGaughey
Clinical Lymphoma, Myeloma & Leukemia. 2010-06-01 - 63 citationsHealth-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care.David J. Kuter, Susan D. Mathias, Mathias J. Rummel, Romeo A. Mandanas, Aristoteles Giagounidis
American Journal of Hematology. 2012-05-01 - 127 citationsRole of p21 RAS in p210 bcr-abl Transformation of Murine Myeloid CellsR. A. Mandanas, D. S. Leibowitz, Kamran Gharehbaghi, T Tauchi, Burgess Gs
Blood. 1993-09-15
Journal Articles
- Bartter's Syndrome: successful treatment with indomethacin and potassium chloride.Mandanas RA, Phil J Nephrol 1:62-66
- Autologous bone marrow transplantation for non-hodgkin's lymphoma: experience at Oklahoma Health Sciences Center 1984-1993.Saez RA, Slease RB, Selby GB, Puckett C, Epstein RB, Mandanas RA, Confer DL, J Okla State Med Assoc 87:358-363
- Autologous bone marrow transplantation for metastatic breast cancer: experience at Oklahoma University Health Sciences Center 1983-1993.Saez RA, Selby GB, Slease RB, Epstein RB, Mandanas RA, Confer DL, J Oklahoma State Med Assoc 87:405-410
Abstracts/Posters
- Open-Label Randomized Comparison of Dolasetron versus Ondansetron for Prevention of Nausea and Vomiting During High-Dose Chemotherapy and Stem Cell Transplantation.R. Mandanas, R. Beveridge, R. Rifkin, H. Wallace, A. Greenspan, G. Spitzer, H Guo, L, Asmar. BBMT 2004:10:Suppl 1:87
- Granulocyte colony-stimulating factor-mobilized donor mononuclear cell infusion after salvage induction therapy in acute leukemia relapsing post-allogeneic marrow tra...Mandanas RA, Saez RA, Selby GB, Confer DL, Proc ASCO 15:86 Abstr 9, ASCO 32nd Annual Meeting, Philadelphia PA
- High-dose chemotherapy (HDCT) as salvage treatment in germ cell tumors (GCT): a multivariate analysis of prognostic variables.Beyer J, Kramar A, Mandanas R, Linkesch W, Greinix A, Droz JP, Pico JL, Diehl A, Bokemeyer C, Schmoll HJ, Nichols CR, Einhorn LH, Siegert W, Proc ASCO 15:239 Abstr 593, ASCO 32nd Annual Meeting, Philadelphia PA
- Join now to see all
Lectures
- Relapse after BMT for leukemia: Options for treatment.BMT Support Group Lecture
- Targeted Therapies in Clinical Oncology.Integris Baptist Cancer Conference
- Infectious Complications following bone marrow transplantation in autologus vs. allogeneic marrow recipients.American College of Physicians Regional Meeting, Traverse City, MI
- Join now to see all
Other
- Fungal Pneumonia.Mandanas, RA, EMedicine from WebMD
http://www.emedicine.com/med/topic1853.htm - Graft Versus Host disease.Mandanas, RA, EMedicine from WebMD
http://www.emedicine.com/MED/topic926.htm
Professional Memberships
- Member
- Member
- Fellow
- Member
Other Languages
- Tagalog, Filipino
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: